TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Janssons Immunbiologiska AB JIBA
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
4,185
|
4,130
|
4,763 |
| Financial expenses |
2
|
5
|
5 |
| Earnings before taxes |
803
|
801
|
1,494 |
| EBITDA |
803
|
805
|
1,503 |
| Total assets |
2,205
|
2,200
|
1,876 |
| Current assets |
2,205
|
2,200
|
1,876 |
| Current liabilities |
375
|
402
|
599 |
| Equity capital |
1,830
|
1,798
|
1,272 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
2
|
2
|
5 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
83.0%
|
81.7%
|
67.8% |
| Turnover per employee |
2,092
|
2,065
|
953 |
| Profit as a percentage of turnover |
19.2%
|
19.4%
|
31.4% |
| Return on assets (ROA) |
36.5%
|
36.6%
|
79.9% |
| Current ratio |
588.0%
|
547.3%
|
313.2% |
| Return on equity (ROE) |
43.9%
|
44.5%
|
117.5% |
| Change turnover |
34
|
-247
|
-408 |
| Change turnover % |
1%
|
-6%
|
-8% |
| Chg. No. of employees |
0
|
-3
|
0 |
| Chg. No. of employees % |
0%
|
-60%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.